HappeningToo topic
Nicotine Polacrilex reports
Browse community reports connected to Nicotine Polacrilex. These reports can show that other people are describing similar experiences, but they do not prove that Nicotine Polacrilex caused a symptom or reaction.
⚕️ Medicine safety note
Community reports do not prove causation, cannot be used to estimate how common a reaction is, and are not medical advice.
41 problems
Abdominal Discomfort while using Nicotine Polacrilex
FDA FAERS contains adverse-event reports in which Nicotine Polacrilex and abdominal discomfort appear together. This does not establish that Nicotine Polacrilex caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Abdominal Pain Upper while using Nicotine Polacrilex
FDA FAERS contains adverse-event reports in which Nicotine Polacrilex and abdominal pain upper appear together. This does not establish that Nicotine Polacrilex caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Abdominal Pain while using Nicotine Polacrilex
FDA FAERS contains adverse-event reports in which Nicotine Polacrilex and abdominal pain appear together. This does not establish that Nicotine Polacrilex caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Anxiety while using Nicotine Polacrilex
FDA FAERS contains adverse-event reports in which Nicotine Polacrilex and anxiety appear together. This does not establish that Nicotine Polacrilex caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Application Site Pain while using Nicotine Polacrilex
FDA FAERS contains adverse-event reports in which Nicotine Polacrilex and application site pain appear together. This does not establish that Nicotine Polacrilex caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Application Site Rash while using Nicotine Polacrilex
FDA FAERS contains adverse-event reports in which Nicotine Polacrilex and application site rash appear together. This does not establish that Nicotine Polacrilex caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Application-site itching while using Nicotine Polacrilex
FDA FAERS contains adverse-event reports in which Nicotine Polacrilex and application-site itching appear together. This does not establish that Nicotine Polacrilex caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Application-site redness while using Nicotine Polacrilex
FDA FAERS contains adverse-event reports in which Nicotine Polacrilex and application-site redness appear together. This does not establish that Nicotine Polacrilex caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Constipation while using Nicotine Polacrilex
FDA FAERS contains adverse-event reports in which Nicotine Polacrilex and constipation appear together. This does not establish that Nicotine Polacrilex caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Cough while using Nicotine Polacrilex
FDA FAERS contains adverse-event reports in which Nicotine Polacrilex and cough appear together. This does not establish that Nicotine Polacrilex caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Decreased Appetite while using Nicotine Polacrilex
FDA FAERS contains adverse-event reports in which Nicotine Polacrilex and decreased appetite appear together. This does not establish that Nicotine Polacrilex caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Diarrhea while using Nicotine Polacrilex
FDA FAERS contains adverse-event reports in which Nicotine Polacrilex and diarrhea appear together. This does not establish that Nicotine Polacrilex caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Dizziness while using Nicotine Polacrilex
FDA FAERS contains adverse-event reports in which Nicotine Polacrilex and dizziness appear together. This does not establish that Nicotine Polacrilex caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Dyspepsia while using Nicotine Polacrilex
FDA FAERS contains adverse-event reports in which Nicotine Polacrilex and dyspepsia appear together. This does not establish that Nicotine Polacrilex caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Excessive sweating while using Nicotine Polacrilex
FDA FAERS contains adverse-event reports in which Nicotine Polacrilex and excessive sweating appear together. This does not establish that Nicotine Polacrilex caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Fatigue while using Nicotine Polacrilex
FDA FAERS contains adverse-event reports in which Nicotine Polacrilex and fatigue appear together. This does not establish that Nicotine Polacrilex caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Feeling Abnormal while using Nicotine Polacrilex
FDA FAERS contains adverse-event reports in which Nicotine Polacrilex and feeling abnormal appear together. This does not establish that Nicotine Polacrilex caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Headache while using Nicotine Polacrilex
FDA FAERS contains adverse-event reports in which Nicotine Polacrilex and headache appear together. This does not establish that Nicotine Polacrilex caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Heart Rate Increased while using Nicotine Polacrilex
FDA FAERS contains adverse-event reports in which Nicotine Polacrilex and heart rate increased appear together. This does not establish that Nicotine Polacrilex caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Hives while using Nicotine Polacrilex
FDA FAERS contains adverse-event reports in which Nicotine Polacrilex and hives appear together. This does not establish that Nicotine Polacrilex caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Hypotension while using Nicotine Polacrilex
FDA FAERS contains adverse-event reports in which Nicotine Polacrilex and hypotension appear together. This does not establish that Nicotine Polacrilex caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Insomnia while using Nicotine Polacrilex
FDA FAERS contains adverse-event reports in which Nicotine Polacrilex and insomnia appear together. This does not establish that Nicotine Polacrilex caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Irritability while using Nicotine Polacrilex
FDA FAERS contains adverse-event reports in which Nicotine Polacrilex and irritability appear together. This does not establish that Nicotine Polacrilex caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Itching while using Nicotine Polacrilex
FDA FAERS contains adverse-event reports in which Nicotine Polacrilex and itching appear together. This does not establish that Nicotine Polacrilex caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Malaise while using Nicotine Polacrilex
FDA FAERS contains adverse-event reports in which Nicotine Polacrilex and malaise appear together. This does not establish that Nicotine Polacrilex caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Nausea while using Nicotine Polacrilex
FDA FAERS contains adverse-event reports in which Nicotine Polacrilex and nausea appear together. This does not establish that Nicotine Polacrilex caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Oral Discomfort while using Nicotine Polacrilex
FDA FAERS contains adverse-event reports in which Nicotine Polacrilex and oral discomfort appear together. This does not establish that Nicotine Polacrilex caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Oropharyngeal Pain while using Nicotine Polacrilex
FDA FAERS contains adverse-event reports in which Nicotine Polacrilex and oropharyngeal pain appear together. This does not establish that Nicotine Polacrilex caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Pain while using Nicotine Polacrilex
FDA FAERS contains adverse-event reports in which Nicotine Polacrilex and pain appear together. This does not establish that Nicotine Polacrilex caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Palpitations while using Nicotine Polacrilex
FDA FAERS contains adverse-event reports in which Nicotine Polacrilex and palpitations appear together. This does not establish that Nicotine Polacrilex caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Rash while using Nicotine Polacrilex
FDA FAERS contains adverse-event reports in which Nicotine Polacrilex and rash appear together. This does not establish that Nicotine Polacrilex caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Shortness of breath while using Nicotine Polacrilex
FDA FAERS contains adverse-event reports in which Nicotine Polacrilex and shortness of breath appear together. This does not establish that Nicotine Polacrilex caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Skin redness while using Nicotine Polacrilex
FDA FAERS contains adverse-event reports in which Nicotine Polacrilex and skin redness appear together. This does not establish that Nicotine Polacrilex caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Sleepiness while using Nicotine Polacrilex
FDA FAERS contains adverse-event reports in which Nicotine Polacrilex and sleepiness appear together. This does not establish that Nicotine Polacrilex caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Taste changes while using Nicotine Polacrilex
FDA FAERS contains adverse-event reports in which Nicotine Polacrilex and taste changes appear together. This does not establish that Nicotine Polacrilex caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Tingling or pins and needles while using Nicotine Polacrilex
FDA FAERS contains adverse-event reports in which Nicotine Polacrilex and tingling or pins and needles appear together. This does not establish that Nicotine Polacrilex caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Tremor while using Nicotine Polacrilex
FDA FAERS contains adverse-event reports in which Nicotine Polacrilex and tremor appear together. This does not establish that Nicotine Polacrilex caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Vomiting while using Nicotine Polacrilex
FDA FAERS contains adverse-event reports in which Nicotine Polacrilex and vomiting appear together. This does not establish that Nicotine Polacrilex caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Weakness while using Nicotine Polacrilex
FDA FAERS contains adverse-event reports in which Nicotine Polacrilex and weakness appear together. This does not establish that Nicotine Polacrilex caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Weight Decreased while using Nicotine Polacrilex
FDA FAERS contains adverse-event reports in which Nicotine Polacrilex and weight decreased appear together. This does not establish that Nicotine Polacrilex caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Weight Increased while using Nicotine Polacrilex
FDA FAERS contains adverse-event reports in which Nicotine Polacrilex and weight increased appear together. This does not establish that Nicotine Polacrilex caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →